Skip to main navigation
  • Investor Home
  • News & Presentations
    News Events Presentations
  • Governance
    Governance Overview Board of Directors Leadership Our ESG Philosophy
  • Financials
    SEC Filings Quarterly Results Annual Reports
  • Stock Information
    Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
  • Resources
    Pipeline Investor FAQs Email Alerts Contact IR

News Releases


Jan 12, 2025

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Re

Read More

Jan 06, 2025

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More
Print Page
RSS Feeds
Email Alerts
Search
Arcutis Biotherapeutics logo

© 2025 Arcutis Biotherapeutics, Inc. All rights reserved.

  • Image of the Linkedin Logo
  • Image of the Twitter Logo
  • Image of the Instagram Logo
  • Contact
  • Legal Disclaimer
  • Privacy Notice
  • Consumer Health Data Privacy Policy
  • Cookies Settings

© 2025 Arcutis Biotherapeutics, Inc. All rights reserved.